AMEX:LABD   Direxion Daily S&P Biotech Bear 3X Shares
Since LABU Long cut short this week from the previous analysis (ran up 15% and stopped at 3% profit). Entering LABD Long as the next big idea for 5:1 R:R.

Fundamentally, I felt this was the right trade long before once the pharmy companies come out with official vaccines that will leave the majority of the industry in despair as only a select few in the industry will continue to benefit from the Covid story.

Idées en relation

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.